Rewiring Drug Research and Development through Human Data-Driven Discovery (HD(3))

In an era of unparalleled technical advancement, the pharmaceutical industry is struggling to transform data into increased research and development efficiency, and, as a corollary, new drugs for patients. Here, we briefly review some of the commonly discussed issues around this counterintuitive inn...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, David B., Racz, Rebecca, Kim, Sarah, Brock, Stephan, Burkhart, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303279/
https://www.ncbi.nlm.nih.gov/pubmed/37376121
http://dx.doi.org/10.3390/pharmaceutics15061673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303279/
https://www.ncbi.nlm.nih.gov/pubmed/37376121
http://dx.doi.org/10.3390/pharmaceutics15061673

Ejemplares similares